May 12, 2017 / 12:42 PM / 6 months ago

BRIEF-Phaserx reports Q1 loss per share $0.35

May 12 (Reuters) - Phaserx Inc:

* Phaserx reports first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.35

* Phaserx Inc - as of March 31, 2017, company had cash, cash equivalents, and marketable securities of $11.9 million

* Phaserx - revising timeline for submission of IND for PRX-OTC to 2018, expect to generate clinical efficacy data in affected patients in H2 of 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below